Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Nephros (NEPH) Accumulated Depreciation & Amortization (2011 - 2025)

Nephros' quarterly Accumulated Depreciation & Amortization came in at $1.1 million in Q4 2025, up 5.45% year-on-year from $1.0 million in Q4 2024, and up 5.45% quarter-over-quarter from $1.0 million in Q4 2024.

Nephros has reported Accumulated Depreciation & Amortization for 15 years, with the latest figure at $1.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 5.45% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (up 5.45% YoY), and the FY2025 full-year result was $1.1 million, up 5.45% from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 stood at $1.1 million, up from $1.0 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $1.1 million in Q4 2025, with the low at $829000.0 in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $957400.0, with a median of $962000.0 recorded in 2023.
  • Year-over-year, Accumulated Depreciation & Amortization decreased 1.66% in 2021 and gained 11.34% in 2022.
  • Tracing NEPH's Accumulated Depreciation & Amortization over 5 years: stood at $829000.0 in 2021, then gained by 11.34% to $923000.0 in 2022, then increased by 4.23% to $962000.0 in 2023, then climbed by 4.89% to $1.0 million in 2024, then grew by 5.45% to $1.1 million in 2025.
  • The last three Accumulated Depreciation & Amortization figures came in at $1.1 million (Q4 2025), $1.0 million (Q4 2024), and $962000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.06 Mn
Dec 31, 2025 1.06 Mn
Dec 31, 2024 1.01 Mn
Dec 31, 2024 1.01 Mn
Dec 31, 2023 962,000.00
Dec 31, 2023 962,000.00
Dec 31, 2022 923,000.00
Dec 31, 2022 923,000.00
Dec 31, 2021 829,000.00
Dec 31, 2021 829,000.00
Dec 31, 2020 843,000.00
Dec 31, 2020 843,000.00
Dec 31, 2019 818,000.00
Dec 31, 2019 818,000.00
Dec 31, 2018 794,000.00
Dec 31, 2018 794,000.00
Dec 31, 2017 765,000.00
Dec 31, 2017 765,000.00
Dec 31, 2016 19,000.00
Dec 31, 2016 19,000.00
Dec 31, 2015 1,000.00
Dec 31, 2015 1,000.00
Dec 31, 2014 6,000.00
Dec 31, 2014 6,000.00
Dec 31, 2013 9,000.00
Dec 31, 2013 9,000.00
Dec 31, 2012 9,000.00
Dec 31, 2012 9,000.00
Dec 31, 2011 2.10 Mn
Dec 31, 2011 2.10 Mn